Kodiak Sciences Inc.

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

KOD$107.10+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

	December 31,2025	December 31,2024
Assets
Current assets:
Cash and cash equivalents	$209,862	$168,074
Prepaid expenses and other current assets	4,954	3,862
Total current assets	214,816	171,936
Restricted cash	6,184	6,184
Property and equipment, net	85,258	102,222
Operating lease right-of-use asset	36,606	46,508
Other assets	8,669	8,728
Total assets	$351,533	$335,578
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$12,863	$3,915
Accrued and other current liabilities	20,607	11,030
Operating lease liability	12,063	10,628
Total current liabilities	45,533	25,573
Long-term operating lease liability	47,117	59,717
Liability related to sale of future royalties	100,000	100,000
Long-term deposit	1,500	—
Total liabilities	194,150	185,290
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.0001 par value – 10,000,000 shares authorized; none issued	—	—
Common stock, $0.0001 par value – 490,000,000 shares authorized; 61,758,454 and 52,726,916 shares issued and outstanding, respectively	6	5
Additional paid-in capital	1,716,082	1,479,021
Accumulated deficit	(1,558,705)	(1,328,738)
Total stockholders’ equity	157,383	150,288
Total liabilities and stockholders’ equity	$351,533	$335,578

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.